<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR9">
 <label>9.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Martin</surname>
    <given-names>JE</given-names>
   </name>
   <name>
    <surname>Louder</surname>
    <given-names>MK</given-names>
   </name>
   <name>
    <surname>Holman</surname>
    <given-names>LA</given-names>
   </name>
   <name>
    <surname>Gordon</surname>
    <given-names>IJ</given-names>
   </name>
   <name>
    <surname>Enama</surname>
    <given-names>ME</given-names>
   </name>
   <name>
    <surname>Larkin</surname>
    <given-names>BD</given-names>
   </name>
   <name>
    <surname>Andrews</surname>
    <given-names>CA</given-names>
   </name>
   <name>
    <surname>Vogel</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Koup</surname>
    <given-names>RA</given-names>
   </name>
   <name>
    <surname>Roederer</surname>
    <given-names>M</given-names>
   </name>
  </person-group>
  <article-title>VRC 301 Study Team A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial</article-title>
  <source>Vaccine</source>
  <year>2008</year>
  <volume>26</volume>
  <fpage>6338</fpage>
  <lpage>6343</lpage>
  <?supplied-pmid 18824060?>
  <pub-id pub-id-type="pmid">18824060</pub-id>
 </element-citation>
</ref>
